McKesson Stock Forecast, Price & News

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" McKesson stock.
View analyst ratings for McKesson or view top-rated stocks.

Wall Street analysts have given McKesson a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but McKesson wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

McKesson saw a decrease in short interest during the month of May. As of May 28th, there was short interest totaling 1,560,000 shares, a decrease of 18.8% from the May 13th total of 1,920,000 shares. Based on an average trading volume of 1,030,000 shares, the days-to-cover ratio is currently 1.5 days. Currently, 1.0% of the company's shares are sold short.
View McKesson's Short Interest.

McKesson is scheduled to release its next quarterly earnings announcement on Monday, August 2nd 2021.
View our earnings forecast for McKesson.

McKesson Co. (NYSE:MCK) released its quarterly earnings data on Thursday, May, 6th. The company reported $5.05 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $5.02 by $0.03. The company earned $59.10 billion during the quarter, compared to analysts' expectations of $61.08 billion. McKesson had a negative net margin of 1.91% and a positive trailing twelve-month return on equity of 95.80%. McKesson's revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the firm earned $4.27 EPS.
View McKesson's earnings history.

McKesson's stock was trading at $135.17 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MCK shares have increased by 36.8% and is now trading at $184.89.
View which stocks have been most impacted by COVID-19.

McKesson announced a quarterly dividend on Thursday, April 29th. Stockholders of record on Tuesday, June 1st will be paid a dividend of $0.42 per share on Thursday, July 1st. This represents a $1.68 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend is Monday, May 31st.
View McKesson's dividend history.

McKesson pays an annual dividend of $1.68 per share and currently has a dividend yield of 0.89%. McKesson has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of McKesson is 9.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, McKesson will have a dividend payout ratio of 8.30% next year. This indicates that McKesson will be able to sustain or increase its dividend.
View McKesson's dividend history.

McKesson announced that its board has initiated a stock repurchase plan on Tuesday, February 2nd 2021, which authorizes the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 6.9% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's leadership believes its stock is undervalued.

McKesson issued an update on its FY 2022 earnings guidance on Thursday, May, 27th. The company provided EPS guidance of 18.850-19.450 for the period, compared to the Thomson Reuters consensus EPS estimate of $18.850. The company issued revenue guidance of $245.38 billion-$252.52 billion, compared to the consensus revenue estimate of $250.66 billion.

10 brokerages have issued 12 month target prices for McKesson's shares. Their forecasts range from $166.00 to $257.00. On average, they expect McKesson's stock price to reach $214.00 in the next year. This suggests a possible upside of 15.7% from the stock's current price.
View analysts' price targets for McKesson or view top-rated stocks among Wall Street analysts.

220 employees have rated McKesson CEO Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among McKesson's employees.

Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all of MCK's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include The Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and The Home Depot (HD).

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

McKesson's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.03%), JPMorgan Chase & Co. (4.80%), Massachusetts Financial Services Co. MA (3.67%), Pzena Investment Management LLC (1.92%), Geode Capital Management LLC (1.81%) and Boston Partners (1.79%). Company insiders that own McKesson stock include Brian S Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Sundeep G Reddy, Thomas L Rodgers and Tracy Faber.
View institutional ownership trends for McKesson.

MCK stock was sold by a variety of institutional investors in the last quarter, including Caisse DE Depot ET Placement DU Quebec, Millennium Management LLC, Dimensional Fund Advisors LP, Point72 Asset Management L.P., Great West Life Assurance Co. Can, Nuveen Asset Management LLC, Nordea Investment Management AB, and Northern Trust Corp. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Marie L/Ca Knowles, Sundeep G Reddy, Thomas L Rodgers, and Tracy Faber.
View insider buying and selling activity for McKesson or view top insider-selling stocks.

MCK stock was purchased by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., Los Angeles Capital Management LLC, JPMorgan Chase & Co., BlackRock Inc., Glenview Capital Management LLC, Arrowstreet Capital Limited Partnership, Federated Hermes Inc., and Bank of New York Mellon Corp.
View insider buying and selling activity for McKesson or or view top insider-buying stocks.

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MCK stock can currently be purchased for approximately $184.89.

McKesson has a market capitalization of $29.25 billion and generates $238.23 billion in revenue each year. The company earns $-4,539,000,000.00 in net income (profit) each year or $17.21 on an earnings per share basis.

McKesson employs 76,000 workers across the globe.

The following companies are subsidiares of McKesson: A.L.I. Technologies, AMISYS Managed Care Systems, Abaton.com, Access Health, Biologics, Celesio, ClarusONE Sourcing Services LLP, CoverMyMeds, D & K Healthcare Resources, Drug Trading Co. Ltd., EN-Chart Scanning Program, Echo, Emendo, Enterprise Systems Inc., HBO & Company, HPR, HealthCom Partners, HealthQx, IMNET Systems, MED3000, McKesson Europe AG, McKesson International Bermuda IP5A Limited, McKesson Medical-Surgical Inc., McKesson Medical-Surgical Supply Chain Services LLC, McKesson Sourcing Services Inc., McKesson Specialty Care Distribution LLC, McKesson Strategic Services Limited, McKesson UK Finance I Limited, McKesson US Finance Corporation, McQueary Brothers, MedVentive, Medcon, MediVation Inc., Medical Specialties Distributors, Medis Health And Pharmaceutical Services, Moore Medical, NDCHealth, Northstar Healthcare Holdings Unlimited Company, Oncology Therapeutics Network, PSS World Medical, Per-Se Technologies, Portico Systems, Practice Partner, RedLine HealthCare, RelayHealth, Rexall, Rosebud Solutions, RxCrossroads, Sterling Medical Services LLC, UDG Healthcare, US Oncology, US Oncology Holdings Inc., Vantage Oncology, Vivalog Technologies, Well.ca, and peerVue.

McKesson was founded in 1833.

The official website for McKesson is www.mckesson.com.

McKesson is headquartered at 6555 STATE HWY 161, IRVING TX, 75039.

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]